retatrutide phase 3 trial Today, we shared new data from two trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Triple hormone receptor agonist retatrutide

What the 2026 Lilly prices mean Lilly announced in March 2026 that KwikPen self-pay access would be available through LillyDirect and major pharmacies nationwide, starting at $299 per month for the 2.5 mg dose

Phase 3 TRIUMPH trials use escalating subcutaneous doses: starting at 2mg weekly, titrating to 4mg, 8mg, and 12mg every 4 weeks

As described, neuronal activity induces myelinationtherefore, it is likely that altered activity due to neuronal dysfunction may lead to changes in activity-dependent myelination (Sams, 2021)

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets

Biallelic variants in BBOX1 cause L-Carnitine deficiency and elevated -butyrobetaine [PMID: 41022783] Laboratory literature summary: Biallelic variants in BBOX1 cause L-Carnitine deficiency and elevated -butyrobetaine

By directly supplying this substrate, D-Ribose supports faster energy metabolism and cellular recovery, particularly after physical exertion or illness